Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3

Armando Bartolazzi, Calogero D'Alessandria, Maria Gemma Parisella et al. · 2008

Read Thyroid Cancer Imaging In Vivo by Targeting the Anti-Apoptotic Molecule Galectin-3 by Armando Bartolazzi, Calogero D'Alessandria, Maria Gemma Parisella et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003768.txt.

Description

Armando Bartolazzi, Calogero D'Alessandria, Maria Gemma Parisella, and colleagues published this imaging study in PLOS ONE in 2008. Thyroid nodules are common, and about ninety percent of them are benign. Telling harmless lumps from cancer before surgery is a standing problem. The team targeted galectin-3, a protein that helps cells avoid death.

They used that target to image thyroid cancer in living patients. Because galectin-3 marks malignant tissue, scans could flag the dangerous nodules. The approach could spare many patients needless surgery on growths that would never harm them. Better triage before surgery is the prize the authors aim at.

Catalog record

CREATORArmando Bartolazzi, Calogero D'Alessandria, Maria Gemma Parisella et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003768

Browse the full library · About the Tower of Babel